About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:5514421
Allelic
Composition
Gfra1tm2Jmi/Gfra1tm1(cre/ERT2)Sjn
Genetic
Background
involves: 129X1/SvJ * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gfra1tm1(cre/ERT2)Sjn mutation (0 available); any Gfra1 mutation (31 available)
Gfra1tm2Jmi mutation (0 available); any Gfra1 mutation (31 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
renal/urinary system
• when pregnant females are treated with tamoxifen at E11.5-12.5, fetuses analyzed at E16.5-17.5 showed a 20% reduction in kidney size relative to controls but kidneys did have a well defined cortex and medulla
• when pregnant females are treated with tamoxifen at E11.5-12.5, fetuses analyzed at E14.5 or E16.5-17.5 showed a small but significant reduction in the number or ureteric bud (UB) tips
• these kidneys had dilated ureteric bud ampullae
• in tamoxifen treated explant cultures, at 72 hours, a 16% decrease in number of ureteric bud tips is observed; beginning at 48 hours in culture, a 25% reduction in relative surface area is measured compared to controls
• in mutants from tamoxifen treated females, UB tip mitotic index (cell proliferation) is reduced relative to controls; levels of apoptosis are not different


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
03/25/2025
MGI 6.24
The Jackson Laboratory